
CONMED
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $335,557 | $343,488 | $317,046 | $373,474 |
Gross Profit | 189,148 | 197,458 | 183,447 | 213,326 |
EBITDA | 56,327 | 61,276 | 38,289 | 55,473 |
EBIT | 37,144 | 39,230 | 25,415 | 36,623 |
Net Income | 19,796 | 23,071 | 13,828 | 16,739 |
Net Change In Cash | 335,557 | 343,488 | 317,046 | 373,474 |
Free Cash Flow | 46,727 | 34,161 | 10,580 | 41,224 |
Cash | 47,972 | 37,328 | 35,030 | 40,817 |
Basic Shares | 30,125 | 30,117 | 30,621 | 31,030 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,374,495 | $1,307,015 | $1,244,744 | $1,045,472 |
Gross Profit | 725,375 | 733,032 | 676,245 | 571,245 |
EBITDA | 176,485 | 251,631 | 172,003 | 27,562 |
EBIT | 102,204 | 200,326 | 120,603 | -41,957 |
Net Income | 47,055 | 132,423 | 64,459 | -80,582 |
Net Change In Cash | 1,374,495 | 1,307,015 | 1,244,744 | 1,045,472 |
Cost of Revenue | 8,836 | |||
Free Cash Flow | 150,883 | 153,884 | 106,316 | 11,580 |
Cash | 40,817 | 24,459 | 24,296 | 28,942 |
Basic Shares | 31,149 | 31,112 | 31,548 | 30,040 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | $1.04 |
2026-06-30 | $1.38 |
2026-03-31 | $0.89 |
2025-12-31 | $1.43 |